Medicare Enrolled

Dr. Thomas Shute, M.D.

Dermatology · Fresno, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
7075 N SHARON AVE, Fresno, CA 93720
5594862000
In practice since 2009 (16 years)
NPI: 1972737567 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shute from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shute? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shute

Dr. Thomas Shute is a dermatology specialist in Fresno, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Shute performed 5,070 Medicare services across 3,672 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shute received a total of $21,540 from 22 pharmaceutical and/or device companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shute is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 11% volume in CA $21,540 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,070
Medicare services
Top 11% in CA for dermatology
3,672
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~317 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,407 $64 $213
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
841 $20 $111
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
620 $48 $267
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
515 $27 $139
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
506 $93 $316
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
252 $22 $81
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
202 $9 $43
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
160 $118 $484
Incision to improve eye fluid flow
A surgical procedure involving an incision to enhance the drainage of fluid within the eye.
128 $689 $2,389
CT scan of cornea
A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye.
113 $28 $110
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
103 $322 $1,387
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
59 $40 $240
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
47 $79 $316
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
33 $31 $139
Laser repair to improve eye fluid flow
A laser procedure used to enhance the drainage of fluid within the eye.
32 $200 $1,238
Eye fluid drainage device insertion
A surgical procedure to insert a device into the eye to help drain excess fluid and reduce pressure.
20 $814 $3,220
Laser destruction of lens tissue
A procedure that uses a laser to destroy or remove tissue within the eye's lens.
19 $319 $1,168
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
13 $26 $129
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
17.0% medium
81.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$21,540
Total received (2018-2024)
Avg $3,077/year across 7 years
Top 2% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
317
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16,826 (78.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,715 (21.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$268
2023
$694
2022
$3,333
2021
$5,718
2020
$2,971
2019
$6,779
2018
$1,778

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$113
Bausch & Lomb Americas Inc.
$44
Astellas Pharma US Inc
$35
Alcon Vision LLC
$28
RxSight Inc
$24
Amgen Inc.
$24
Top 3 companies account for 71.7% of 2024 payments
All-time payments by company (2018-2024) ›
Aerie Pharmaceuticals, Inc.
$13,865
Alcon Vision LLC
$3,246
Ivantis, Inc
$816
AbbVie Inc.
$671
Alcon Laboratories Inc
$518
Bausch & Lomb, a division of Bausch Health US, LLC
$506
Allergan Inc.
$460
Sight Sciences, Inc.
$408
TissueTech, Inc.
$313
Sun Pharmaceutical Industries Inc.
$139
ABBVIE INC.
$135
Glaukos Corporation
$97
Allergan, Inc.
$87
Bausch & Lomb Americas Inc.
$80
Astellas Pharma US Inc
$35
Shire North American Group Inc
$34
Kala Pharmaceuticals, Inc.
$25
Carl Zeiss Meditec USA, Inc.
$24
RxSight Inc
$24
Amgen Inc.
$24
Johnson & Johnson Surgical Vision, Inc.
$20
Omeros Corporation
$15
Top 3 companies account for 83.2% of all-time payments
Associated products mentioned in payments ›
ACTIVEFOCUS · AcrySof · AcrySof IQ PanOptix UV IOL · AcrySof IQ VIVITY · AcrySof IQ VIVITY IOL · BEPREVE · BromSite (bromfenac ophthalmic solution) 0.075% · COMBIGAN · Centurion · CyPass · DURYSTA · HYDRUS Microstent · Hydrus · Hydrus Microstent · INVELTYS · IOLMaster 700 · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · Izervay · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · OMNI(R) SURGICAL SYSTEM (US) · Omidria · Prokera · RXSIGHT CONTACT LENS · Rhopressa · Rocklatan · Simbrinza · TEPEZZA · VERACITY SURGICAL · VYZULTA · XEN · XIIDRA · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (78%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for dermatology in CA.

Looking for a dermatology specialist in Fresno?
Compare dermatologists in the Fresno area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
27
Per 100K population
2.7
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shute is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with speaking/promotional industry engagement in the top 2% of CA peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Shute experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Shute performed 1,407 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shute receive payments from pharmaceutical companies?
Yes. Dr. Shute received a total of $21,540 from 22 companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shute's costs compare to other dermatologists in Fresno?
Dr. Shute's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shute) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →